Manhattan Scientifics, Inc. (MHTX)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Jul 13, 2026

Manhattan Scientifics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
--0.050.050.050.1
Revenue Growth
--0%0%-48.45%-
Gross Profit
--0.050.050.050.1
Operating Income
-0.68-0.7-0.68-0.69-0.68-1.03
Net Income
-1.06-1.17-2.73-3.644.31-1.22
Earnings Per Share
-0.00-0.00-0.00-0.010.01-0.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
0.040.070.180.230.350.26
Total Debt
0.060.060.110.130.10.08
Net Cash (Debt)
-0.020.010.070.10.250.18
Net Cash Growth
--89.23%-36.27%-59.04%36.07%110.34%
Net Cash Per Share
-0.000.000.000.000.000.00

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
-0.11-0.19-0.35-0.42-0.39-0.32
Capital Expenditures
-----0-
Free Cash Flow
-0.11-0.19-0.35-0.42-0.39-0.32
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---1358.00%-1374.00%-1350.00%-1056.70%
Pretax Margin
---5460.00%-7278.00%8628.00%-1259.79%
Profit Margin
---5460.00%-7278.00%8628.00%-1259.79%
FCF Margin
---698.00%-842.00%-784.00%-325.77%

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PE Ratio
----5.51-
PS Ratio
--89.49178.97475.7960.38